R01.Aim 2.Study 1: IsoReach

January 7, 2025 updated by: James Lanphier Patton, Shirley Ryan AbilityLab

Error-enhanced Learning & Recovery in 2 & 3 Dimensions

To determine the effects of 3D isometric movement training in healthy participants and impaired participants due to a stroke.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Researchers have found that neurotypical adults are able to train movement skills when sensory sources, such as proprioception, are altered using isometric conditions and visual feedback in a two-dimensional environment.Building off this knowledge, the investigators plan to apply similar techniques to both neurotypical adults and stroke survivors with impaired movement, but in a three-dimensional environment. The investigators will ask participants to practice a unilateral virtual reality targeted reaching task using a robotic arm in a 3D visual display system mounted over the arm. Participants will be given visual feedback of their arm through a virtual avatar displayed on the screen. First, they will complete unconstrained targeted reaching and then complete targeted reaching with the robotic arm constrained in a fixed position ("isometric" movement). The forces applied to constrain the robotic arm will be translated to the virtual avatar arm on the screen, and it will look as if their arm is moving. The investigators will compare perpendicular errors (maximum difference between the ideal reaching trajectory and the actual) made in unconstrained and constrained movement conditions. The investigators aim to determine if the two movement conditions yield similar error responses when sensory sources are altered in a 3D environment.

Study Type

Interventional

Enrollment (Estimated)

56

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Courtney Celian, OTR/L

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Recruiting
        • Shirley Ryan AbilityLab
        • Contact:
        • Principal Investigator:
          • James L Patton, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria, neurotypical participants

  • 18 years old

No history of stroke

Ability to provide informed consent .

Exclusion criteria, neurotypical participants

Severe medical problems (including cardiovascular, orthopedic, or neurological)

Medical problems affecting movement, range of motion, strength, or coordination of the upper extremities.

Visual deficits that would influence the ability to perform the experiment . This will be assessed using the following assessments:

  1. Visual field deficits will be assessed using the BIVABA acuity testing. (cutoff score > 20/100)
  2. Depth perception deficits will be assessed using the Stereofly test (require at least an angle of stereopsis at 16 inches is 3,552 seconds of arc).

    4) Blood pressure above 140 systolic and/or 90 diastolic mmHG

    5) Blood oxygen reading of less than 92% by finger pulse oximeter testing.

    Inclusion Criteria , Stroke participants

    • 18 years old

    Chronic stroke (8+ months post)

    Available medical records and radiographic information about lesion locations

    Hemiparesis

    Primary motor cortex involvement

    Some degree of both shoulder and elbow movement capability

    Exclusion Criteria , Stroke participants

    Bilateral paresis

    Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to perform the experiment, This will be assessed using the Mini Mental State Examination31, with cut-off scores (adjusted for education level) as follows:

    Participants whose education are 7th grade or lower, a score 22 or lower

    Participants whose education attainment level is 8th grade or some high school (but not a graduate), a score of 24 or lower

    Participants whose education attainment level is high school graduate, a score of 25 or lower

    Participants whose education attainment level is some college or higher, a score 26 or lower

    Visual deficits, and hemispatial neglect that would prevent the participants from seeing the targets. A vision test will be done if the participant indicates in their screen that their stroke has affected their vision. This will be tested using the following assessments:

    Visual field loss will be assessed using the BIVABA acuity test10. (cutoff score > 20/100)

    Visual Extinction and Inattention using Star Cancellation Test9. (cutoff score of <44)

    Depth perception deficits will be assessed using the Stereofly test (require at least an angle of stereopsis at 16 inches is 3,552 seconds of arc).

    Modified Ashworth score of 4 at shoulder or elbow joints.

    Rated below 15 on the FMUE scale

    Inability to provide an informed consent

    severe current medical problems

    Severe sensory deficit in the affected limb (Cannot be absent in any part of affected UE)

    diffuse/multiple lesion sites or multiple stroke events

    Inability to attain and maintain testing positions

    Botox or other botulinum toxin injection to the affected upper extremity within the previous 4 months

    Concurrent participation in upper extremity rehabilitation either as part of a research intervention protocol or a prescribed therapy

    Neurological, neuromuscular, or orthopedic diseases (i.e. injuries to your affected arm or hand)

    Other neurological issues (Parkinson's, CP)

    Blood Pressure above 140 systolic and/or 90 diastolic mmHg

    Blood oxygen reading of less than 92% on finger pulse oximetry testing.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Isometric Reaching condition
In this arm the participant participates in "Isometric Reaching" in which they are not allowed to freely reach to the target, instead the forces they apply on the robot handle drives a reaching arm simulation
The intervention of "Isometric Reaching" is the process of restricting the participant's hand movement in place, while using the forces they apply to the robot handle to drive a reaching arm simulation
No Intervention: Control Reaching condition
In this condition the participant moves toward target freely and the visual feedback is based on hand position and not an arm simulation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perpendicular Error
Time Frame: through study completion, an average of 1 year.
Maximum distance between the ideal reaching trajectory and the actual trajectory made in unconstrained and constrained movement conditions
through study completion, an average of 1 year.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: James L Patton, PhD, Shirley Ryan AbilityLab

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 17, 2024

Primary Completion (Estimated)

May 1, 2029

Study Completion (Estimated)

May 1, 2029

Study Registration Dates

First Submitted

September 4, 2024

First Submitted That Met QC Criteria

October 22, 2024

First Posted (Actual)

October 24, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 7, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • STU00220740

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Isometric Reaching

Subscribe